1y return+70.3%S&P 500 +20.9%
3y return+65.2%S&P 500 +68.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since December 31, 2021: $98 against $157 in the S&P 500.2
Blue Owl Capital Holdings LPS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| SPCXSpace Exploration Techn Corp | $239.0M | 36.3% | New |
| AKTSAktis Oncology Inc | $99.0M | 15.0% | −2.9% |
| CGEMCullinan Therapeutics Inc | $28.0M | 4.3% | −19.4% |
| LRMRLarimar Therapeutics Inc | $27.9M | 4.2% | +28.7% |
| NCDLNuveen Churchill Direct Lend | $26.6M | 4.0% | |
| MPLTMaplight Therapeutics Inc | $26.2M | 4.0% | −27.4% |
| COFCapital One Finl Corp | $24.0M | 3.7% | New |
| OBDCBlue Owl Capital Corporation | $22.2M | 3.4% | |
| FISNDeep Fission Inc | $14.7M | 2.2% | New |
| DELLDell Technologies Inc | $14.2M | 2.2% | +137.1% |
| HLLYHolley Inc | $11.2M | 1.7% | +3.3% |
| EYPTEyepoint Inc | $10.9M | 1.7% | −16.4% |
| SGMTSagimet Biosciences Inc | $9.7M | 1.5% | +277.5% |
| CRVSCorvus Pharmaceuticals Inc | $9.1M | 1.4% | +11.7% |
| ARTVArtiva Biotherapeutics Inc | $8.5M | 1.3% | New |
| CMPXCompass Therapeutics Inc | $7.9M | 1.2% | +23.2% |
| CNDTConduent Inc | $7.4M | 1.1% | |
| RYTMRhythm Pharmaceuticals Inc | $6.8M | 1.0% | |
| CMPSCompass Pathways PLC | $6.4M | 1.0% | New |
| RAREUltragenyx Pharmaceutical In | $6.1M | 0.9% | −39.7% |
| PVLAPalvella Therapeutics Inc Ne | $5.5M | 0.8% | +16.0% |
| IMAImagenebio Inc | $5.4M | 0.8% | −4.3% |
| VRDNViridian Therapeutics Inc | $4.8M | 0.7% | New |
| IMMXImmix Biopharma Inc | $4.5M | 0.7% | −20.1% |
| ORICOric Pharmaceuticals Inc | $4.3M | 0.7% | +166.7% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| PVLAPalvella Therapeutics Inc Ne | December 31, 2024 | +1173.5% | $5.5M |
| DELLDell Technologies Inc | June 30, 2025 | +251.9% | $14.2M |
| MPLTMaplight Therapeutics Inc | December 31, 2025 | +104.0% | $26.2M |
| IMMXImmix Biopharma Inc | December 31, 2025 | +97.1% | $4.5M |
| EYPTEyepoint Inc | December 31, 2024 | +91.9% | $10.9M |
| AKTSAktis Oncology Inc | March 31, 2026 | +80.2% | $99.0M |
| CGEMCullinan Therapeutics Inc | December 31, 2023 | +78.7% | $28.0M |
| SGMTSagimet Biosciences Inc | December 31, 2023 | +42.6% | $9.7M |
| CMPXCompass Therapeutics Inc | December 31, 2023 | +40.4% | $7.9M |
| ORICOric Pharmaceuticals Inc | December 31, 2025 | +32.4% | $4.3M |
Sold off last quarter
- Engene Holdings IncCUSIP 29286M105 was $30.1M
- Compass Pathways PLCCUSIP 20451W901 was $5.1M
- CVEOCiveo Corp Cda was $4.8M
- Kalvista Pharmaceuticals IncCUSIP 483497103 was $4.3M
- OVIDOvid Therapeutics Inc was $4.2M
- PLRXPliant Therapeutics Inc was $3.7M
- Larimar Therapeutics IncCUSIP 517125900 was $1.9M
- Engene Holdings IncCUSIP 29286M113 was $1.3M
- EPDEnterprise Prods Partners L was $1.2M
- OPTXWSyntec Optics Hldgs Inc was $867K
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +19.6% | +14.8% |
| March 31, 2026 | +3.0% | −4.6% |
| December 31, 2025 | +12.5% | +2.4% |
| September 30, 2025 | +22.9% | +7.8% |
| June 30, 2025 | +5.1% | +10.5% |
| March 31, 2025 | −18.7% | −4.6% |
| December 31, 2024 | −8.9% | +2.1% |
| September 30, 2024 | +10.6% | +5.4% |
| June 30, 2024 | −12.7% | +4.0% |
| March 31, 2024 | +20.1% | +10.0% |
| December 31, 2023 | +5.2% | +11.2% |
| September 30, 2023 | +2.2% | −3.6% |
| June 30, 2023 | +6.7% | +8.3% |
| March 31, 2023 | +12.9% | +7.0% |
| December 31, 2022 | −10.2% | +7.1% |
| September 30, 2022 | +2.8% | −5.3% |
| June 30, 2022 | −28.0% | −16.5% |
| March 31, 2022 | −26.1% | −4.9% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Blue Owl Capital Holdings LP Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1858703&type=13F-HR&dateb=&owner=include&count=40CIK 1858703
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1858703/000119312526345031/Filed August 11, 2026 · accession 0001193125-26-345031